NHS Greater Glasgow and Clyde in Scotland will begin a 12-month trial in August 2019 to test the use of wearables in remotely monitoring patients with Chronic Obstructive Pulmonary Disease (COPD), one of a growing number of wearable trials for medical purposes. Mortality rates for COPD in the United Kingdom are the twelfth highest in the world, with Scotland in particular seeing a larger number of both hospital admissions and deaths. It is hoped that the trial will help reduce the frequency which with COPD patients are hospitalized; currently, an average of 10 COPD patients per day are admitted to NHS Greater Glasgow and Clyde’s emergency room alone and, without intervention, that number is expected to increase. These admissions are painful, stressful, and time consuming for patients, and cost the NHS around £6,000 each. The trial will include 400 patients and, after it is completed, the data will be evaluated to consider whether the model can be scaled and deployed across the rest of the NHS to help the 1.2 million people in the United Kingdom with COPD. If successful, it could also be used for other conditions, particularly diabetes.
You must be a subscriber to view this ABI Insight.
To find out more about subscribing contact a representative about purchasing options.